These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7. Bremer E, Samplonius DF, Peipp M, van Genne L, Kroesen BJ, Fey GH, Gramatzki M, de Leij LF, Helfrich W. Cancer Res; 2005 Apr 15; 65(8):3380-8. PubMed ID: 15833872 [Abstract] [Full Text] [Related]
9. Therapy of human T-cell acute lymphoblastic leukaemia with a combination of anti-CD7 and anti-CD38-SAPORIN immunotoxins is significantly better than therapy with each individual immunotoxin. Flavell DJ, Boehm DA, Noss A, Warnes SL, Flavell SU. Br J Cancer; 2001 Feb 15; 84(4):571-8. PubMed ID: 11207056 [Abstract] [Full Text] [Related]
10. Improved stability and yield of Fv targeted superantigen by introducing both linker and disulfide bond into the targeting moiety. Hao HJ, Jiang YQ, Zheng YL, Ma R, Yu DW. Biochimie; 2005 Aug 15; 87(8):661-7. PubMed ID: 15927340 [Abstract] [Full Text] [Related]
14. Construction, expression, and activities of L49-sFv-beta-lactamase, a single-chain antibody fusion protein for anticancer prodrug activation. Siemers NO, Kerr DE, Yarnold S, Stebbins MR, Vrudhula VM, Hellström I, Hellström KE, Senter PD. Bioconjug Chem; 1997 Aug 15; 8(4):510-9. PubMed ID: 9258449 [Abstract] [Full Text] [Related]
15. Agonistic activity of a CD40-specific single-chain Fv constructed from the variable regions of mAb G28-5. Ledbetter JA, Francisco JA, Siegall CB, Gilliland LK, Hollenbaugh D, Aruffo A, Siadak AW, Mischel-Petty N, Grosmaire LS, Gordon ML, Brown TJ, Moran-Davis P, Mittler RS, Kiener PA, Nadler SG. Crit Rev Immunol; 1997 Aug 15; 17(5-6):427-35. PubMed ID: 9419430 [Abstract] [Full Text] [Related]
16. Production and characterization of an active single-chain variable fragment antibody recognizing CD25. Muramatsu H, Yoshikawa K, Hayashi T, Takasu S, Kawada Y, Uchida K, Sato S, Takahashi T, Saga S, Ueda R. Cancer Lett; 2005 Jul 28; 225(2):225-36. PubMed ID: 15978327 [Abstract] [Full Text] [Related]
17. Stabilization of a recombinant Fv fragment by base-loop interconnection and V(H)-V(L) permutation. Brinkmann U, Di Carlo A, Vasmatzis G, Kurochkina N, Beers R, Lee B, Pastan I. J Mol Biol; 1997 Apr 25; 268(1):107-17. PubMed ID: 9149145 [Abstract] [Full Text] [Related]
18. Cytotoxicity of human RNase-based immunotoxins requires cytosolic access and resistance to ribonuclease inhibition. Erickson HA, Jund MD, Pennell CA. Protein Eng Des Sel; 2006 Jan 25; 19(1):37-45. PubMed ID: 16243897 [Abstract] [Full Text] [Related]
19. Design, expression, purification, and characterization, in vitro and in vivo, of an antimelanoma single-chain Fv antibody fused to the toxin gelonin. Rosenblum MG, Cheung LH, Liu Y, Marks JW. Cancer Res; 2003 Jul 15; 63(14):3995-4002. PubMed ID: 12873997 [Abstract] [Full Text] [Related]
20. [Expression, structure prediction and functional analysis of murine single-chain fragment variable antibody against human cervical cancer]. Wang Y, Li X, Chen W. Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jan 15; 26(1):16-21. PubMed ID: 16495168 [Abstract] [Full Text] [Related] Page: [Next] [New Search]